Skip to main content

Table 5 Direction of influence on SR conclusions

From: A study of the value of requesting information from drug manufacturers for systematic reviews; 9 years of experience from the drug effectiveness review project

  Total affecting conclusions Favors dossier drug Favors a competitor No difference Other
Unpublished 25 13 (52%) 2 (8.0%) 10 (40%) 2 (8.0%)
Psychiatry topics 31 15 (48%) 6 (19%) 13 (42%) 2 (6%)